IL-10 in the tumor microenvironment inhibits the production of IFNγ and TNFα; it also downregulates MHC class II in monocytes, establishing TIL anergy, and, in doing so, it enhances tumor growth [41,42]. Here, IFNG is linked to neoplasm.